Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
By harnessing the power of a GLP-1, GIP, and glucagon receptor agonist simultaneously, this medication is being studied for effects on appetite, metabolic signaling, and energy balance
Other medical conditions : Ozempic is approved for type 2 diabetes, and Wegovy is approved for weight loss in those who are overweight or obese
Similar to Rybelsus, Ozempic also belongs to the drug class called glucagon-like peptide-1 (GLP-1) receptor agonists
The medication increases signals that tell your brain you're full and satisfied, which typically makes high-sugar foods feel less rewarding
US$ 28.55
US$ 26.42
US$ 21.26
US$ 28.95
